Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03058575 · ClinicalTrials.gov registry record · NA
Effects of a Novel Food Product Containing Microbiota Accessible Carbohydrates on the Human Microbiome
A NA study, sponsored by Access Business Group.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT03058575: Completed NA study, sponsored by Access Business Group.
NCT03058575 is a NA study that has completed, run by Access Business Group. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03058575, a NA study, has completed, sponsored by Access Business Group.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
This is a randomized, 2-period crossover study aimed at assessing the effect of taking a food supplement containing a blend of microbial accessible carbohydrates on the diversity of the gut microbiome. Impacts to the skin, scalp and oral microbiomes; blood inflammatory biomarkers; quality and quantity of sleep; gastrointestinal quality of life; bowel habits, and facial skin features will also be evaluated.
Interventions
- OTHER Control
- DIETARY_SUPPLEMENT Dietary MACs
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2017-01-16 |
| Est. Completion | 2017-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03058575
The ClinicalTrials.gov registry entry for NCT03058575 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Access Business Group, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT03058575 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03058575 about?
NCT03058575 is a clinical study titled "Effects of a Novel Food Product Containing Microbiota Accessible Carbohydrates on the Human Microbiome". This is a randomized, 2-period crossover study aimed at assessing the effect of taking a food supplement containing a blend of microbial accessible carbohydrates on the diversity of the gut microbiome. Impacts to the skin, scalp and oral microbiomes; blood inflammatory biomarkers; quality and quanti...
What is the current status of trial NCT03058575?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2017-01-16. Estimated completion is 2017-09-30.
What interventions are being tested in trial NCT03058575?
The interventions under investigation include: Control (OTHER), Dietary MACs (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03058575?
This trial is sponsored by Access Business Group, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.